| Literature DB >> 30475230 |
Matthew S Parsons1, Wen Shi Lee1, Anne B Kristensen1, Thakshila Amarasena1, Georges Khoury1, Adam K Wheatley1,2, Arnold Reynaldi3, Bruce D Wines4, P Mark Hogarth4, Miles P Davenport3, Stephen J Kent1,2,5.
Abstract
A considerable body of evidence suggests that Fc-dependent functions improve the capacity of broadly neutralizing antibodies (BnAbs) to protect against and control HIV-1 infection. This phenomenon, however, has not been formally tested in robust cell-associated macaque simian-human immunodeficiency virus (SHIV) models with newer-generation BnAbs. We studied both the WT BnAb PGT121 and a LALA mutant of PGT121 (which has impaired Fc-dependent functions) for their ability to protect pigtail macaques from an i.v. high-dose cell-associated SHIVSF162P3 challenge. We found that both WT and LALA PGT121 completely protected all 12 macaques studied. Further, partial depletion of NK cells, key mediators of Fc-dependent functions, did not abrogate the protective efficacy of PGT121 in 6 macaques. Additionally, in animals with established SHIVSF162P3 infection, SHIV viremia levels were equally rapidly reduced by LALA and WT PGT121. Our studies suggest that the potent neutralizing capacity of PGT121 renders the Fc-dependent functions of the Ab at least partially redundant. These findings have implications for Ab-mediated protection from and control of HIV-1 infection.Entities:
Keywords: AIDS vaccine; AIDS/HIV; Immunology
Mesh:
Substances:
Year: 2018 PMID: 30475230 PMCID: PMC6307963 DOI: 10.1172/JCI122466
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808